Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Identifieur interne : 000049 ( Hal/Checkpoint ); précédent : 000048; suivant : 000050Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Auteurs : Alexis Brice [France]Source :
- Movement Disorders [ 0885-3185 ] ; 2007.
English descriptors
- mix :
Abstract
Stimulation of the subthalamic nucleus (STN) improves motor signs in patients with levodopa-responsive Parkinson's disease (PD). Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause Parkinsonism. We assessed 69 patients under STN stimulation and found heterozygous LRRK2 mutations in 9 (G2019S in 8 and T2031S in 1). The age at onset of PD, the clinical characteristics before or after neurosurgery, and the clinical response to STN stimulation were similar in both groups. Two patients with the G2019S LRRK2 mutation still benefited from STN stimulation, 9 and 10 years after surgery. Patients with LRRK2 mutations are, therefore, good candidates for STN stimulation.
Url:
DOI: 10.1002/mds.21178
Links toward previous steps (curation, corpus...)
Links to Exploration step
Hal:hal-00194967Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.</title><author><name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-3037" status="VALID"><orgName>Neurologie et thérapeutique expérimentale</orgName><desc><address><addrLine>GH Pitié-Salpetrière 47, Boulevard de L'Hopital 75651 PARIS CEDEX 13</addrLine><country key="FR"></country></address><ref type="url">http://www.u289.ifrns.chups.jussieu.fr/</ref></desc><listRelation><relation active="#struct-93591" type="direct"></relation><relation name="U679" active="#struct-300002" type="direct"></relation><relation active="#struct-300636" type="direct"></relation></listRelation><tutelles><tutelle active="#struct-93591" type="direct"><org type="institution" xml:id="struct-93591" status="VALID"><orgName>Université Pierre et Marie Curie - Paris 6</orgName><orgName type="acronym">UPMC</orgName><desc><address><addrLine>4 place Jussieu - 75005 Paris</addrLine><country key="FR"></country></address><ref type="url">http://www.upmc.fr/</ref></desc></org></tutelle><tutelle name="U679" active="#struct-300002" type="direct"><org type="institution" xml:id="struct-300002" status="VALID"><orgName>INSERM</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle><tutelle active="#struct-300636" type="direct"><org type="institution" xml:id="struct-300636" status="VALID"><orgName>IFR70</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">HAL</idno><idno type="RBID">Hal:hal-00194967</idno><idno type="halId">hal-00194967</idno><idno type="halUri">https://hal.archives-ouvertes.fr/hal-00194967</idno><idno type="url">https://hal.archives-ouvertes.fr/hal-00194967</idno><idno type="doi">10.1002/mds.21178</idno><date when="2007">2007</date><idno type="wicri:Area/Hal/Corpus">000060</idno><idno type="wicri:Area/Hal/Curation">000060</idno><idno type="wicri:Area/Hal/Checkpoint">000049</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.</title><author><name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-3037" status="VALID"><orgName>Neurologie et thérapeutique expérimentale</orgName><desc><address><addrLine>GH Pitié-Salpetrière 47, Boulevard de L'Hopital 75651 PARIS CEDEX 13</addrLine><country key="FR"></country></address><ref type="url">http://www.u289.ifrns.chups.jussieu.fr/</ref></desc><listRelation><relation active="#struct-93591" type="direct"></relation><relation name="U679" active="#struct-300002" type="direct"></relation><relation active="#struct-300636" type="direct"></relation></listRelation><tutelles><tutelle active="#struct-93591" type="direct"><org type="institution" xml:id="struct-93591" status="VALID"><orgName>Université Pierre et Marie Curie - Paris 6</orgName><orgName type="acronym">UPMC</orgName><desc><address><addrLine>4 place Jussieu - 75005 Paris</addrLine><country key="FR"></country></address><ref type="url">http://www.upmc.fr/</ref></desc></org></tutelle><tutelle name="U679" active="#struct-300002" type="direct"><org type="institution" xml:id="struct-300002" status="VALID"><orgName>INSERM</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle><tutelle active="#struct-300636" type="direct"><org type="institution" xml:id="struct-300636" status="VALID"><orgName>IFR70</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author></analytic><idno type="DOI">10.1002/mds.21178</idno><series><title level="j">Movement Disorders</title><idno type="ISSN">0885-3185</idno><imprint><date type="datePub">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="mix" xml:lang="en"><term>"LRRK2"</term><term>"Parkinson's disease</term><term>"dardarine"</term><term>"deep brain stimulation"</term><term>"subthalamic nucleus"</term><term>LRRK2</term><term>Parkinson's disease</term><term>dardarine</term><term>deep brain stimulation</term><term>genetics</term><term>genetics"</term><term>subthalamic nucleus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Stimulation of the subthalamic nucleus (STN) improves motor signs in patients with levodopa-responsive Parkinson's disease (PD). Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause Parkinsonism. We assessed 69 patients under STN stimulation and found heterozygous LRRK2 mutations in 9 (G2019S in 8 and T2031S in 1). The age at onset of PD, the clinical characteristics before or after neurosurgery, and the clinical response to STN stimulation were similar in both groups. Two patients with the G2019S LRRK2 mutation still benefited from STN stimulation, 9 and 10 years after surgery. Patients with LRRK2 mutations are, therefore, good candidates for STN stimulation.</div></front></TEI><hal api="V3"><titleStmt><title xml:lang="en">Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.</title><author role="aut"><persName><forename type="first">Alexis</forename><surname>Brice</surname></persName><email>brice@ccr.jussieu.fr</email><idno type="halauthor">201812</idno><affiliation ref="#struct-3037"></affiliation><affiliation ref="#struct-16845"></affiliation></author><editor role="depositor"><persName><forename>Alexis</forename><surname>Brice</surname></persName><email>alexis.brice@upmc.fr</email></editor><funder>ANR-05-NEUR-019 APOPIS EU Contract No.LSHM-CT-2003-503330</funder></titleStmt><editionStmt><edition n="v1" type="current"><date type="whenSubmitted">2007-12-07 18:08:14</date><date type="whenModified">2007-12-07 18:08:14</date><date type="whenReleased">2007-12-07 18:08:14</date><date type="whenProduced">2007</date></edition><respStmt><resp>contributor</resp><name key="123209"><persName><forename>Alexis</forename><surname>Brice</surname></persName><email>alexis.brice@upmc.fr</email></name></respStmt></editionStmt><publicationStmt><distributor>CCSD</distributor><idno type="halId">hal-00194967</idno><idno type="halUri">https://hal.archives-ouvertes.fr/hal-00194967</idno><idno type="halBibtex">brice:hal-00194967</idno><idno type="halRefHtml">Movement Disorders, Wiley, 2007, 22 (1), pp.119-122. <10.1002/mds.21178></idno><idno type="halRef">Movement Disorders, Wiley, 2007, 22 (1), pp.119-122. <10.1002/mds.21178></idno></publicationStmt><seriesStmt><idno type="stamp" n="APHP" p="INSERM">AP-HP</idno><idno type="stamp" n="UNIV-PARIS6">Université Pierre et Marie Curie - Paris VI</idno><idno type="stamp" n="UPMC">Université Pierre et Marie Curie</idno></seriesStmt><notesStmt><note type="audience" n="2">International</note><note type="popular" n="0">No</note><note type="peer" n="1">Yes</note></notesStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.</title><author role="aut"><persName><forename type="first">Alexis</forename><surname>Brice</surname></persName><email>brice@ccr.jussieu.fr</email><idno type="halAuthorId">201812</idno><affiliation ref="#struct-3037"></affiliation><affiliation ref="#struct-16845"></affiliation></author></analytic><monogr><idno type="halJournalId" status="VALID">17211</idno><idno type="issn">0885-3185</idno><idno type="eissn">1531-8257</idno><title level="j">Movement Disorders</title><imprint><publisher>Wiley</publisher><biblScope unit="volume">22</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="pp">119-122</biblScope><date type="datePub">2007</date><date type="dateEpub">2006</date></imprint></monogr><idno type="doi">10.1002/mds.21178</idno><idno type="pubmed">17080443</idno></biblStruct></sourceDesc><profileDesc><langUsage><language ident="en">English</language></langUsage><textClass><keywords scheme="author"><term xml:lang="en">Parkinson's disease</term><term xml:lang="en">genetics</term><term xml:lang="en">LRRK2</term><term xml:lang="en">dardarine</term><term xml:lang="en">subthalamic nucleus</term><term xml:lang="en">deep brain stimulation</term><term xml:lang="en">"Parkinson's disease</term><term xml:lang="en">genetics"</term><term xml:lang="en">"LRRK2"</term><term xml:lang="en">"dardarine"</term><term xml:lang="en">"subthalamic nucleus"</term><term xml:lang="en">"deep brain stimulation"</term></keywords><classCode scheme="halDomain" n="sdv.neu">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]</classCode><classCode scheme="halTypology" n="ART">Journal articles</classCode></textClass><abstract xml:lang="en">Stimulation of the subthalamic nucleus (STN) improves motor signs in patients with levodopa-responsive Parkinson's disease (PD). Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause Parkinsonism. We assessed 69 patients under STN stimulation and found heterozygous LRRK2 mutations in 9 (G2019S in 8 and T2031S in 1). The age at onset of PD, the clinical characteristics before or after neurosurgery, and the clinical response to STN stimulation were similar in both groups. Two patients with the G2019S LRRK2 mutation still benefited from STN stimulation, 9 and 10 years after surgery. Patients with LRRK2 mutations are, therefore, good candidates for STN stimulation.</abstract><particDesc><org type="consortium">Projet ANR Neurosciences 2005</org><org type="consortium">Projet européen Apopis</org></particDesc></profileDesc></hal></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000049 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000049 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Hal
|étape= Checkpoint
|type= RBID
|clé= Hal:hal-00194967
|texte= Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
}}
| This area was generated with Dilib version V0.6.23. |  |